Most recently, it's been discovered that conolidine and the above mentioned derivatives act about the atypical chemokine receptor 3 (ACKR3. Expressed in identical parts as classical opioid receptors, it binds to some big range of endogenous opioids. Not like most opioid receptors, this receptor acts as being a scavenger https://paulj641ehh2.eedblog.com/profile